What is BIO Protocol? Revolutionizing Biotech Through Decentralized Science (DeSci)

BIO is a curation and liquidity protocol for DeSci, designed to accelerate biotechnology. It empowers global communities of patients, scientists, and biotech experts to collaboratively fund, develop, and own biotechnological projects and intellectual property (IP).

The team behind BIO previously launched Molecule, a platform for tokenizing early-stage biomedical projects, and VitaDAO, the largest decentralized community for longevity research. Building on these successes, BIO aims to foster an on-chain scientific economy through decentralized funding, incentives, and liquidity.

The BIO Token provides access to BIO’s network of scientific communities and intellectual property, unlocking extensive opportunities in the DeSci space.

Key Features of BIO Protocol

Curation

• BIO token holders can vote on the inclusion of new BioDAOs in the ecosystem, promoting a community-driven approach to funding scientific projects.

Funding

• Approved BioDAOs receive support from vBIO stakers, who gain early access to funding rounds.

Liquidity

• BIO Protocol helps BioDAOs manage liquidity by combining BIO tokens with BioDAO tokens in liquidity pools, creating efficient markets for scientific IP.

Rewards (Bio/acc Rewards)

• BIO tokens are distributed as incentives to BioDAOs that achieve specific milestones, thereby enhancing network value.

Meta-Governance

• BIO holders can participate in the governance of various BioDAOs and make decisions regarding scientific IP assets.

Investor Details:

• Binance Labs: Investment amount undisclosed.

Governance Token

BIO is the governance token of the BIO Protocol.
Token holders can use $BIO to:

• Vote on which BioDAOs should receive support (Curation function).
• Decide on future issuance or distribution of BIO tokens.
• Implement accelerator programs for network growth.

Token Utility:

Holders gain access to:

• Governance rights in network BioDAOs.
• Early access to BioDAO funding rounds.
• Rewards for contributing health data or participating in clinical studies.
• New health products funded by BioDAOs.

Tokenomics

• Total Supply: 3,320,000,000

Distribution:

• Community: 56%
  • Community Auction: 20%
  • Community Airdrop: 6%
• Ecosystem Incentives: 25%
• Molecule Ecosystem Fund: 5%
• Investors: 13.6%
• Core Contributors: 21.2%
• Advisors: 4.2%
• Molecule: 5%

Contracts (ETH-Mainnet):

• BIO Token Contract: 0xcb1592591996765Ec0eFc1f92599A19767ee5ffA
• vBIO (vesting BIO) Token Contract: 0x0d2ADB4Af57cdac02d553e7601456739857D2eF4

Market and Listing Details

The token is currently traded on gate.io in the pre-market with a capitalization of $1.2 billion and an FDV of $3.1 billion.
Gate.io BIO/USDT

Binance Listing: Scheduled for Friday, January 3, 2025.

The token remains strong in the pre-market. Investors, advisors, and core contributors will not receive tokens at launch. In the first year, 97% of tokens will remain with the community. DeSci is a relatively underexplored sector with promising potential this year.